Evidence map›Paper›PMID 33613629›Full record

ArticleFrontiers in genetics2021

Enhanced Expression of

Mancheng Gong, Erlin Song, Guiying Huang, Wenjun Ni, Wenjing Dong, Runqiang Yuan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mancheng GongDepartment of Urology, The People's Hospital of Zhongshan, Zhongshan, China.
Erlin SongDepartment of Urology, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Guiying HuangDepartment of Urology, The People's Hospital of Zhongshan, Zhongshan, China.
Wenjun NiDepartment of Urology, The People's Hospital of Zhuhai, Zhuhai, China.
Wenjing DongDepartment of Oncology, The People's Hospital of Zhongshan, Zhongshan, China.
Runqiang YuanDepartment of Urology, The People's Hospital of Zhongshan, Zhongshan, China.
Zhongshan People's Hospital · CNFirst Affiliated Hospital of Harbin Medical University · CNZhuhai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is one of the most common urogenital malignancies in the world, and there are no adequate prognostic indicators.

Indexed as

bioinformatics analysisbladder cancerCNTD2prognosissurvival

Identifiers

PMID33613629
PMCPMC7886781
OpenAlexW3127810003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.